FindMyKOL
Clinical trialNCT05610345CompletedInterventional

The Effect of Placental Cord Drainage on Postpartum Blood Loss

NCT05610345 is an interventional trial sponsored by University of Tennessee. As of 21 Nov 2026, it is completed. It studies Postpartum Hemorrhage. The registry lists an enrollment of 71 participants at 1 site in 1 country. The registry lists a start date of 12 Nov 2022 and a primary completion date of 1 Jun 2023.

SponsorUniversity of Tennessee →Enrollment71Postpartum Hemorrhage
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT05610345
FieldValue
Registry IDNCT05610345
StatusCompleted
Study typeInterventional trial
Lead sponsorUniversity of Tennessee
Enrollment71
Registered sites1
Countries1
ConditionsPostpartum Hemorrhage
Start12 Nov 2022
Primary completion1 Jun 2023
Study completion1 Jun 2023
Last update posted13 Feb 2024

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

To determine if placental cord drainage decreases the blood loss after spontaneous vaginal delivery

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Tennessee, United States1 site
  • Regional One Health

    Memphis

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew YorkNYMassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennessee: 1 siteTN1North CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT05610345

Each answer restates registry values shown on this page.

What is NCT05610345?

NCT05610345 is an interventional trial sponsored by University of Tennessee. It studies Postpartum Hemorrhage.

Who leads NCT05610345?

The registry names John Schorge, MD, FACS (study chair, Regional One Health) as the overall official.

Where does NCT05610345 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

When did NCT05610345 end?

The registry lists a primary completion date of 1 Jun 2023 and a study completion date of 1 Jun 2023. The sponsor last updated the record on 13 Feb 2024.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.